The life sciences sector faces complex and constantly changing regulations. The firm is designed to guide you through this regulatory environment at all stages of development as well as the life of your products and services. We notably advise on the following topics:
Kanavape case: The Advocate General of the CJEU concludes that French restrictions on CBD are contrary to European law
15 May 2020COVID-19: The French competent health authority (ANSM) modifies the advertising visas calendar
30 April 2020The entry into application of Regulation (EU) 2017/745 of April 5th, 2017 relating to medical devices (MDR) is postponed by one year
25 April 2020